AU2018102140A4 - Method for preparing sacubitril intermediate - Google Patents

Method for preparing sacubitril intermediate Download PDF

Info

Publication number
AU2018102140A4
AU2018102140A4 AU2018102140A AU2018102140A AU2018102140A4 AU 2018102140 A4 AU2018102140 A4 AU 2018102140A4 AU 2018102140 A AU2018102140 A AU 2018102140A AU 2018102140 A AU2018102140 A AU 2018102140A AU 2018102140 A4 AU2018102140 A4 AU 2018102140A4
Authority
AU
Australia
Prior art keywords
compound
formula
preparation
acid
recited
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2018102140A
Inventor
Shuang HUANG
Weisi LI
Siqing WU
Qiang Xu
Yi XUE
Jian Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangsu Zhongbang Pharmaceutical Co ltd
Original Assignee
JIANGSU ZHONGBANG PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JIANGSU ZHONGBANG PHARMACEUTICAL CO Ltd filed Critical JIANGSU ZHONGBANG PHARMACEUTICAL CO Ltd
Application granted granted Critical
Publication of AU2018102140A4 publication Critical patent/AU2018102140A4/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Abstract The present invention discloses a synthetic method of an Entresto intermediate and belongs to the 5 field of chemical pharmacy. The synthetic method includes the following steps: reacting a starting material of glycine, with diterbutyl dicarbonate ester under an alkaline condition, performing dehydrogenation and amino protection, and performing substitution, deprotection and salt formation with a compound of a formula II in the presence of a chiral catalyst by virtue of a "one-pot process" to obtain a compound of a formula III having a chiral intermediate; reducing the 10 compound of the formula III, refining and salifying to obtain a compound of a formula IV, and performing amino protection on the compound of the formula IV and the diterbutyl dicarbonate ester, thereby obtaining a target product of a formula I, that is, (R)-tert-butyl-(1-([1,1'-biphenyl]-4-yl)-3-hydroxyl propane-2-yl) carbamate. According to the synthetic method of the Entresto intermediate provided by the present invention, needed raw 15 materials and reagents are readily available, reaction conditions are mild, total yield is high, cost is low, the refining involves only two salt processes, after-treatment operation is simple, and product quality is reliable and stable. The whole process is very suitable for industrial production.

Description

The present invention belongs to the field of chemical pharmacy, and particularly relates to a intermediate preparation process of an Entresto which is a key component in an anti-heart-failure drug of an Entresto combination drug.
Background Art
Entresto (formerly known as LCZ696) is a chronic heart failure drug researched and developed by Novartis, a Swiss pharmaceutical giant. The Entresto is used for treating NYHA II-IV level patients with heart failure, and acts on a neuroendocrine system of the heart in multiple manners. The drug is a remarkable breakthrough in the field of heart failure treatment over the past 25 years, and is expected to successfully shake an overall heart failure treatment framework unmodified over the past 10 years. The Entresto has been approved by FDA on July 23, 2015. At present, the Entresto is being reviewed by health management organizations all over the world including Canada, Switzerland and European Union. Once the Entresto is approved to be used for treating heart failure with low ejection fraction by the global health management organizations, sales volume of the Entresto is estimated to be expected to break through 5 billion dollars. A structural formula of the Entresto is as follows:
Patents for synthesis of a key intermediate (R)-tert-butyl-(l-([l,l'-biphenyl]-4-yl)-3-hydroxyl propane-2-yl) carbamate involved in a preparation process of Entresto mainly include a patent
2018102140 31 May 2018
WO2014032627 and a patent EP1903027. The synthetic method of the (R) -tert-butyl-(l-([l,l'-biphenyl]-4-yl)-3-hydroxyl propane-2-yl) carbamate disclosed in the patents WO2014032627 and EP1903027 mainly includes the following steps: taking 4-bromobiphenyl as a starting material, preparing the material into a Grignard reagent, and carrying out a condensation reaction with a raw material (S)-epoxy chloropropane or (S) -epoxy-tert-butyl ether to obtain a corresponding hydroxyl compound; carrying out a
Mitsunobu reaction on hydroxyl condensate and succinimide in the presence of diethyl azodicarboxylate/triphenylphosphine to perform configuration inversion so as to obtain an intermediate pyrrolidine-2,5-diketone; further removing amino protection groups of the intermediate in a concentrated acid, and performing nucleophilic substitution under an alkaline condition to obtain (R)-3-([l,l'-biphenyl]-4-yl)-2-aminopropyl-l-ol hydrochloride; and finally, performing amino protection on the salt and Boc anhydride, thereby obtaining the key intermediate (R)-tert-butyl-(l-([1,1'-biphenyl]-4-yl)-3-hydroxyl propane-2-yl) carbamate. The route is complicated in synthesis steps, a Grignard reaction is involved in the first reaction step, and since a reaction is suddenly initiated in an amplification process, the reaction is violent, and risk of scouring easily occurs. In addition, the triphenylphosphine is used in the second step; a large amount of phosphorus triphenyl oxide is produced in the system after reaction completion and is difficult to be removed, thereby influencing measurement in the next step, causing that usage of the Boc is difficult to be determined during amino protection and causing poor product quality of unreacted Boc anhydride in a residual part of the product. A specific synthetic route is as follows:
Summary of the Invention
The present invention overcomes defects in the prior art. By virtue of a novel process, a reaction route is shortened by adopting a “one-pot” process, after-treatment is simplified, total yield is high, and quality of a prepared product is excellent. The problem that the above method cannot be completely used for industrialization is solved.
2018102140 31 May 2018
Another purpose of the present invention provides a novel route of preparing (R)-tert-butyl-(l-([l,l'-biphenyl]-4-yl)-3-hydroxyl propane-2-yl) carbamate. The process includes the following steps:
HOOC
Note: Y is sulfate radical or halogen (1) reacting a starting material of glycine with diterbutyl dicarbonate ester under an alkaline condition, performing dehydrogenation and amino protection, performing substitution with a compound of a formula II in the presence of a chiral catalyst by virtue of a “one-pot process”, and performing deprotection with an acid to obtain a compound of a formula III having a chiral intermediate;
(2) reducing the compound of the formula III in presence of a reducing agent, refining and salifying in presence of a protonic acid to obtain a compound of a formula IV;
(3) performing amino protection on the compound of the formula IV and the diterbutyl dicarbonate ester at low temperature, thereby obtaining a target product of a formula I, that is, (R)-tert-butyl-(l-([l,l'-biphenyl]-4-yl)-3-hydroxyl propane-2-yl) carbamate.
HOOC
Note: Y is sulfate radical or halogen (1) reacting a starting material of glycine, with diterbutyl dicarbonate ester in a polar solvent under an alkaline condition, performing dehydrogenation and amino protection, performing substitution with a compound of a formula II in the presence of a chiral catalyst by virtue of a “one-pot process”, and performing deprotection to get the salt formatior under an acid condition to obtain a compound of a formula III after substitution, wherein the chiral catalyst is a compound
2018102140 31 May 2018
R-2-amino-2'-hydroxyl-1,1'-dinaphthalene of a formula V;
Ri isHorCl-C3 alkyl
V (2) reducing the compound of the formula III in presence of a reducing agent, refining and 5 salifying in presence of a strong protonic acid to obtain a compound of a formula IV;
(3) performing amino protection on the compound of the formula IV and the diterbutyl dicarbonate ester at a low temperature, thereby obtaining a target product, that is, [1,1 '-biphenyl]-4-yl)-1 -(hydroxymethyl)ethyl] tert-butyl carbamate.
In the step (1), the alkaline condition is selected from one of metal sodium, sodium hydroxide, 10 potassium hydroxide, sodium methylate, sodium ethoxide, sodium hydride, potassium tert-butoxide and sodium tert-butoxide.
In the step (1), the polar solvent is selected from one of methanol, ethanol, isopropanol, 1,4-dioxane and tetrahydrofuran.
In the step (1), Ri is one of hydrogen, methyl, ethyl, propyl and isopropyl.
In the step (1), a molar ratio of the chiral catalyst to the compound of the formula II is 0.3%-0.7%.
In the step (1), the acid is selected from one of hydrochloric acid (or gas), hydrobromic acid (or gas) and sulfuric acid for performing acid treatment, preferably hydrochloric acid.
In the step (2), the reducing agent is one of sodium borohydride, potassium borohydride and lithium aluminum tetrahydride.
In the step (2), the strong protonic acid is selected from one of hydrochloric acid, hydrobromic acid and sulfuric acid.
In the step (3), the reaction temperature of the compound of the formula IV and the diterbutyl dicarbonate ester is -10-10°C, preferably -5-5°C.
In the step (3), the reaction temperature of the compound of the formula IV and the diterbutyl 25 dicarbonate ester is -5-5 °C.
Beneficial Effects:
According to the synthetic method of an Entresto intermediate, that is, (R)-tert-butyl-(l-([l,l'-biphenyl]-4-yl)-3-hydroxyl propane-2-yl) carbamate provided by the present invention, needed raw materials and reagents are readily available, cost is relatively low, reaction steps are fewer, reaction conditions are mild, the refining involves only two salt processes, after-treatment operation is simple, and product quality is reliable and stable.
2018102140 31 May 2018
Compared with the prior art, the present invention has the advantages as follows: glycine and 4-bromomethylbiphenyl are subjected to chiral substitution by virtue of a chiral catalyst and then reduced, and an intermediate (R)-3-([l,l'-biphenyl]-4-yl)-2-aminopropyl-l-ol hydrochloride may be obtained in two steps; a conversion rate is high, total yield is 70%-80%, and complicated operation and low yield caused by too long route are avoided; and according to the salifying and refining methods of the obtained intermediate, the target product with stable quality may be obtained without refining, and the product is very suitable for industrial production of Entresto.
Brief Description of the Drawings
Figure 1 is a nuclear magnetism map of a compound I;
Figure 2 is a mass spectrum of the compound I; and Figure 3 is a map of related substances of the compound I.
Detailed Description of the Invention
Example 1
Preparation of (R)-3-([l,l'-biphenyl])-2-aminopropionic acid hydrochloride (III)
1000 g of methanol and 40.0 g of (l.Omol) sodium hydroxide were added into 3F of reaction flask, stirred at room temperature and dissolved to be clarified, then 37.6 g of (0.5mol) glycine and 109.2 g of (0.5mol) diterbutyl dicarbonate ester were added, the reflux time 3h at 65-75°C; the system was cooled down to a room temperature after completion of the reaction, 0.43 g of (1.5 mmol) (R)-(-)-2-amino-2'-hydroxy-l,l'-biphenyl was added, and a solution prepared from 123.6 g of (0.5mol) 4-bromomethylbiphenyl and 500 g of methanol was dropped while stirring; the solution was stirred at the room temperature for 2 h after dropping completion, and after completion of the reaction, as monitored by TEC ; the system was filtered, and the filtrate was filled into a clean reaction flask, HC1 gas was introduced into the system while stirring until pH of the system is 1.0-2.0, introduction of the hydrochloric acid gas was stopped, the system was continuously stirred at the room temperature for 1 -2 h, filtering was perfomed to get the filter cake, and a filter cake was dried, thereby obtaining 121.2 g of a white solid, wherein a value ee is 99.0%, HPEC = 99.0%, and molar yield is 87.3%.
Preparation of (R)-3-([l,l'-biphenyl])-2-aminopropanol hydrochloride (IV)
55.6 g of (0.2mol) (R)-3-([l,l'-biphenyl])-2-aminopropionic acid hydrochloride and 2E of tetrahydro furan were added into 3E of reaction flask, 20.3 g of (0.2mol) triethylamine was dropped at a room temperature, the system was stirred until the solid was completely dissolved to be clarified, cooled down to 0°C, stirred for 30 min and filtered, filtrate was cooled down to 0°C again under nitrogen protection, 11.4 g of (0.3mol) lithium aluminum tetrahydride was added in
2018102140 31 May 2018 batches after the temperature was stabilized, the system was heated to reflux after adding completion, the temperature was maintained and the system was reacted for 24 h, and after completion of the reaction, as monitored by TLC ; the system was cooled down to 0°C again, a solution prepared from 4 g of sodium hydroxide and 10 g of water was dropped after the temperature was stabilized, 10 g of water was added again after dropping completion, the system was heated to the room temperature, stirred for 1 h and filtered, the filtered was concentrated under reduced pressure to provide a residue, concentrated hydrochloric acid was added into the system to regulate a pH value to 1-2, the system was stirred at 5-10°C for 2-4 h and filtered, the filter cake was rinsed with a small amount of ethyl acetate and dried, thereby obtaining 46.7 g of a white solid, wherein HPLC = 99.0%, and yield is 88.5%.
Preparation of N-Noc-(R)-3-([l,l'-biphenyl])-2-aminopropanol (I)
1. 39.6 g of (0.15mol) (R)-3-([l,l'-biphenyl])-2-aminopropanol hydrochloride and a solution prepared from 9.0 g of (0.23mol) sodium hydroxide and 100 g of water were added into IL of reaction flask, the materials were stirred until the solid was white flocculus, the system was stirred for about 25 min, and cooled; a solution prepared from 36.0 g of (0.17mol) diterbutyl dicarbonate ester and lOOg of a di chloromethane solution was dropped at 0-5 °C; after dropping completion, react for 4h at a room temperature , after completion of the reaction, as monitored by TLC; the solution was separated,the dichloromethane layer was separated out, the water layer was extracted with 100 g of dichloromethane again, and the organic layer was merged; steaming was performed to remove lOOg of the organic layer under a reduced pressure, 100 g of n-heptane was added, stirred and crystallized at 0 °C, suction filtration was performed, the filter cake was rinsed with the n-heptane, and dried, thereby obtaining 45.7 g of a white solid, wherein a value ee is 99.7%, HPLC = 99.0%, and yield is 93.1%.
Example 2
Preparation of (R)-3-([l,l'-biphenyl])-2-aminopropionic acid hydrochloride (III)
500 g of ethanol and 34.0 g of (0.5mol) sodium ethoxide were added into 2L of reaction flask, and stirred at room temperature, 18.8 g of (0.25 mol) glycine and 54.6 g of (0.25 mol) diterbutyl dicarbonate ester were added, this mixture was heated to reflux for 3 hour at 75-85°C ;cooled down to after completion of the reaction,cool down to room temperature, 0.37 g of (1.25 mmol) (R)-(-)-2-aminomethyl-2'-hydroxy-l,l'-biphenyl was added, and a solution prepared from 61.8 g of (0.25 mol) 4-bromomethylbiphenyl and 200 g of ethanol was dropped while stirring; stirring was performed at the room temperature for 2 h after dropping completion, and after completion of the reaction, as monitored by TLC ; the system was filtered, and the filtrate was filled into a clean reaction flask, concentrated hydrochloric acid was introduced into the system while stirring until pH of the reaction solution was 1.0-2.0, the system was continuously stirred at the room temperature for 1-2 h, and filtered, and a filter cake was dried, thereby obtaining 62.8 g of a white
2018102140 31 May 2018 solid, wherein a value ee is 99.2%, HPLC = 99.0%, and molar yield is 90.5%.
Preparation of (R)-3-([l,l'-biphenyl])-2-aminopropanol sulfate (IV)
41.7 g of (0.15mol) (R)-3-([l,l'-biphenyl])-2-aminopropionic acid hydrochloride and 1.5L of tetrahydro furan were added into 2L of reaction flask, 15.2 g of (0.15mol) triethylamine was dropped at room temperature, stirring was performed until the solid was completely dissolved to be clarified, the system was cooled down to 0°C, stirred for 30 min and filtered, filtrate was cooled down to 0°C again under nitrogen protection, 8.5 g of (0.23mol) lithium aluminum tetrahydride was added in batches after the temperature was stabilized, the system was heated to reflux after adding completion, the temperature was maintained andreacted for 24h, and monitored by TLC until the raw materials are completely reacted; the system was cooled down to 0°C again, a solution prepared from 3.0 g of sodium hydroxide and 8 g of water was dropped after the temperature is stabilized, 8 g of water was added again after dropping completion, the system was heated to the room temperature, stirred for 1 h and filtered, rotary evaporation was performed on the filtrate under a reduced pressure to be dry, 50% of a sulfuric acid solution was added into the system, the PH was regulated to 1-2, the system was stirred at 5-10°C for 2-4 h and filtered, a filter cake was pulped with 100 g of water, and the filter cake was rinsed with a small amount of ethyl acetate after filtering, and dried, thereby obtaining 45.5 g of a white solid, wherein HPLC = 99.0%, and yield is 93.2%.
Preparation of N-Noc-(R)-3-([l,l'-biphenyl])-2-aminopropanol (I)
2. 32.5 g of (O.lmol) (R)-3-([l,l'-biphenyl])-2-aminopropanol sulfate and a solution prepared from 6.0 g of (0.15mol) sodium hydroxide and 70 g of water were added into IL of reaction flask, and stirred until the solid was white flocculus, the system was stirred for about 25 min, and cooled; a solution prepared from 24.0 g of (O.llmol) diterbutyl dicarbonate ester and 70g of a dichloromethane solution was dropped at 0-5°C; a reaction was carried out at room temperature for 4 h after dropping completion, after completion of the reaction, as monitored by TLC; the solution was separated, a dichloromethane layer was separated out, a water layer was extracted with 70 g of dichloromethane again, and the organic layer was merged;70g organic solvent was produced by vacuum distillation, 70 g of n-heptane was added, stirred and crystallized at 0 °C, suction filtration was performed, and the filter cake was rinsed with the n-heptane, and dried, thereby obtaining 30.3 g of a white solid, wherein a value ee is 99.7%,
HPLC 99.0%, and yield is 92.5%.
Example 3
Preparation of (R)-3-([l,l'-biphenyl])-2-aminopropionic acid sulfate (III)
600 g of tetrahydrofuran subjected to non-aqueous treatment and 36.0 g of (0.38 mol) sodium tert-butoxide were added into 2L of reaction flask, and stirred at room temperature, 18.8 g of (0.25 mol) glycine and 54.6 g of (0.25 mol) diterbutyl dicarbonate ester were added, the reflux time 1.5h at 65-75°C; the system was cooled down to a room temperature after reaction completion, 0.5 g of (1.75 mmol) (R)-(-)-2-amino-2'-hydroxy-l,l'-biphenyl was added, and a solution prepared from
2018102140 31 May 2018
61.8 g of (0.25 mol) 4-bromomethylbiphenyl and 200 g of ethanol was dropped while stirring; stirring was performed at the room temperature for 1.5 h after dropping completion, and after completion of the reaction, as monitored by TLC ; the system was filtered, and the filtrate was filled into a clean reaction flask, concentrated hydrochloric acid was introduced into the system while stirring until pH of the reaction solution was 1.0-2.0, the system was continuously stirred at the room temperature for 1-2 h, and filtered, and a filter cake was dried, thereby obtaining 79.9 g of a white solid, wherein a value ee is 99.5%, HPLC = 99.0%, and molar yield is 94.1 %. Preparation of (R)-3-([l,l'-biphenyl])-2-aminopropanol bromate (IV)
50.9 g of (0.15mol) (R)-3-([l,l'-biphenyl])-2-aminopropionic acid hydrochloride and 1.5L of 10 tetrahydro furan were added into a 2L of reaction flask, 15.2 g of (0.15mol) triethylamine was dropped at a room temperature, stirring was performed until the solid was completely dissolved to be clarified, the system was cooled down to 0°C, stirred for 30 min, and filtered, filtrate was cooled down to 0°C again under nitrogen protection, 12.4 g of (0.23mol) potassium borohydride was added in batches after the temperature was stabilized, the system was heated to reflux after adding completion, the temperature was maintained and a reaction was carried out for 24 h, and after completion of the reaction, as monitored by TLC ; the system was cooled down to 0°C again, a solution prepared from 3.0 g of (0.08 mol) sodium hydroxide and 8 g of water was dropped after the temperature was stabilized, 8 g of water was added again after dropping completion, the system was heated to the room temperature, stirred for 1 h, and filtered, rotary evaporation was performed on the filtrate under a reduced pressure to be dry, hydrogen bromide gas was introduced into the system, the PH was regulated to 1-2, the system was stirred at 5-10°C for 2-4 h, and filtered, and the filter cake was rinsed with a small amount of ethyl acetate, and dried, thereby obtaining 43.1 g of a light yellow solid, wherein HPLC = 99.0%, and yield is 93.2%.
Preparation of N-Noc-(R)-3-([l,l'-biphenyl])-2-aminopropanol (I)
3. 30.8 g of (O.lmol) (R)-3-([l,l'-biphenyl])-2-aminopropanol bromate and a solution prepared from 6.0 g of (0.15mol) sodium hydroxide and 70 g of water were added into a IL of reaction flask, and stirred until the solid was white flocculus, the system was stirred for about 25 min, and cooled; a solution prepared from 24.0 g of (O.llmol) diterbutyl dicarbonate ester and 70g of a dichloromethane solution was dropped at 0-5 °C; after dropping completion, react for 4h at a room temperature, after completion of the reaction, as monitored by TLC; the solution was separated, a di chloromethane layer was separated out, a water layer was extracted with 70 g of dichloromethane again, and the organic layer was merged; 70g organic solvent was produced by vacuum distillation, 70 g of n-heptane was added, stirred and crystallized at 0°C, suction filtration was performed, and the filter cake was rinsed with the n-heptane, and dried, thereby obtaining 29.3 g of a white solid, wherein a value ee is 99.8%, HPLC = 99.0%, and yield is 89.5%.

Claims (10)

  1. (1) reacting a starting material of glycine, with diterbutyl dicarbonate ester in a polar solvent under an alkaline condition, performing dehydrogenation and amino protection, performing substitution with a compound of a formula II in the presence of a chiral catalyst by virtue of a “one-pot process”, and performing deprotection and salt formation under an acid condition to obtain a compound of a formula III after substitution, wherein the chiral catalyst is a compound Ri-2-amino-2'-hydroxyl-l,l'-dinaphthalene of a formula V, and Ri is alkane of H or C1-C3;
  2. 2. The preparation method as recited in claim 1, wherein in the step (1), the alkaline condition is selected from one of metal sodium, sodium hydroxide, potassium hydroxide, sodium methylate, sodium ethoxide, sodium hydride, potassium tert-butoxide and sodium tert-butoxide.
    20 3. The preparation method as recited in claim 1, wherein in the step (1), the polar solvent is selected from one of methanol, ethanol, isopropanol, 1,4-dioxane and tetrahydro furan.
    (2) reducing the compound of the formula III in presence of a reducing agent, refining and salifying in presence of a strong protonic acid to obtain a compound of a formula IV;
  3. (3) performing amino protection on the compound of the formula IV and the diterbutyl
    15 dicarbonate ester at a low temperature, thereby obtaining a target product, that is, [l,r-biphenyl]-4-yl-l-(hydroxymethyl)ethyl] tert-butyl carbamate.
  4. 4. The preparation method according to claim 1, wherein in the step (1), Ri is one of hydrogen,
    2018102140 31 May 2018 methyl, ethyl, propyl and isopropyl.
  5. 5 one of hydrochloric acid, hydrobromic acid and sulfuric acid for performing acid treatment.
    5. The preparation method as recited in claim 1, wherein in the step (1), a molar ratio of the chiral catalyst to the compound of the formula II is 0.3%-0.7%.
  6. 6. The preparation method as recited in claim 1, wherein in the step (1), the acid is selected from
  7. 7. The preparation method as recited in claim 1, wherein in the step (2), the reducing agent is one of sodium borohydride, potassium borohydride and lithium aluminum tetrahydride.
  8. 8. The preparation method as recited in claim 11, wherein in the step (2), the strong protonic acid is selected from one of hydrochloric acid, hydrobromic acid and sulfuric acid.
    10
  9. 9. The preparation method as recited in claim 1, wherein in the step (3), the reaction temperature of the compound of the formula IV and the diterbutyl dicarbonate ester is -10-10 °C.
  10. 10. The preparation method as recited in claim 9, wherein in the step (3), the reaction temperature of the compound of the formula IV and the diterbutyl dicarbonate ester is -5-5 °C.
AU2018102140A 2017-07-27 2018-05-31 Method for preparing sacubitril intermediate Active AU2018102140A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710625599.1 2017-07-27
CN201710625599.1A CN107382779B (en) 2017-07-27 2017-07-27 Preparation method of shakubiqu intermediate

Publications (1)

Publication Number Publication Date
AU2018102140A4 true AU2018102140A4 (en) 2019-10-03

Family

ID=60342605

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2018102140A Active AU2018102140A4 (en) 2017-07-27 2018-05-31 Method for preparing sacubitril intermediate
AU2018305416A Pending AU2018305416A1 (en) 2017-07-27 2018-05-31 Method for preparing sacubitril intermediate

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2018305416A Pending AU2018305416A1 (en) 2017-07-27 2018-05-31 Method for preparing sacubitril intermediate

Country Status (3)

Country Link
CN (1) CN107382779B (en)
AU (2) AU2018102140A4 (en)
WO (1) WO2019019795A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115215916A (en) * 2022-08-15 2022-10-21 湖南原野医药有限公司 Method for preparing key intermediate of alphaxalone

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107382779B (en) * 2017-07-27 2020-04-17 江苏中邦制药有限公司 Preparation method of shakubiqu intermediate
CN110183357B (en) * 2019-06-13 2021-09-24 甘肃皓天医药科技有限责任公司 Preparation method for preparing Sacubitril intermediate
CN111205204A (en) * 2020-01-16 2020-05-29 南京红杉生物科技有限公司 Sacubitril intermediate and synthetic method and application thereof
CN115745841B (en) * 2021-09-03 2024-04-16 凯特立斯(深圳)科技有限公司 Preparation method of sakubi-qu intermediate
CN114805135A (en) * 2022-03-29 2022-07-29 浙江美诺华药物化学有限公司 Synthetic method of key intermediate of Sacubitril

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101362708B (en) * 2008-09-05 2012-05-16 浙江工业大学 Synthesis method of tert-butyl-[2-(biphenyl-4-yl)-1-(hydroxymethyl)ethyl] carbamate
CN101555211B (en) * 2009-05-13 2012-01-25 浙江九洲药业股份有限公司 Chemical synthesis method of 2-acylamino-3-biphenyl propionic acid
AR092278A1 (en) * 2012-08-31 2015-04-08 Novartis Ag PROCESS FOR OBTAINING N-ACILIC DERIVATIVES OF BIFENYL-ALANINE AND RELATED INTERMEDIARIES
CN105985225A (en) * 2015-02-12 2016-10-05 博瑞生物医药(苏州)股份有限公司 Preparation methods for LCZ-696 and intermediate thereof
CN106187808A (en) * 2015-05-08 2016-12-07 苏州鹏旭医药科技有限公司 The preparation method of AHU-377, AHU-377 intermediate and the preparation method of AHU-377 intermediate
JPWO2016199688A1 (en) * 2015-06-10 2018-03-29 住友化学株式会社 Method for producing carbamate compounds
CN105168205A (en) * 2015-08-18 2015-12-23 泰力特医药(湖北)有限公司 Preparation method for dual inhibitor LCZ696 of angiotensin II receptor and neprilysin
CN105330569A (en) * 2015-09-11 2016-02-17 天台宜生生化科技有限公司 Preparation method of (R)-2-(N-tertbutyloxycarbonylamino)biphenylpropanol
CN106380421B (en) * 2016-08-26 2017-12-08 中国科学院上海有机化学研究所 Synthetic method bent Sha Kubi
CN107382779B (en) * 2017-07-27 2020-04-17 江苏中邦制药有限公司 Preparation method of shakubiqu intermediate

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115215916A (en) * 2022-08-15 2022-10-21 湖南原野医药有限公司 Method for preparing key intermediate of alphaxalone

Also Published As

Publication number Publication date
AU2018305416A1 (en) 2019-05-30
CN107382779B (en) 2020-04-17
CN107382779A (en) 2017-11-24
WO2019019795A1 (en) 2019-01-31

Similar Documents

Publication Publication Date Title
AU2018102140A4 (en) Method for preparing sacubitril intermediate
US8884033B2 (en) Process for preparing aminobenzoylbenzofuran derivatives
US9499507B2 (en) Method for preparing 5-amino-benzoyl-benzofuran derivatives
KR101126825B1 (en) Method for producing z-1-phenyl-1-diethylaminocarbonyl-2-aminomethyl cyclopropane hydrochloride
TWI382975B (en) Process for preparing 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine
US8912345B2 (en) Method for preparing optically pure (−)-clausenamide compound
CN112979552B (en) Preparation method of high-purity dexmedetomidine hydrochloride
US10047037B2 (en) Method for producing 2-amino-substituted benzaldehyde compound
CN104829557A (en) Novel compound 1-[2-(2,4-dimethylphenylthio)phenyl]-2-oxopiperazine and its preparation method and use in vortixetine synthesis
US20190300484A1 (en) An improved process for the preparation of regorafenib
JP6030752B2 (en) Method for producing oxetane-3-ylmethanamine
CN107602527B (en) Preparation method of statin drug intermediate
CN103228635B (en) Tartrate is utilized to be separated pyrrolotriazine derivatives enantiomer
EP3986867B1 (en) Processes and intermediates for the preparation of 2-(2,6-dichlorophenyl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl]ethenone
US20070249839A1 (en) Process for the Preparation of Losartan Potassium Form I
US10626102B2 (en) Process for the synthesis of efinaconazol
JP2020070296A (en) Method for producing linagliptin
KR20180050091A (en) A method for preparation of (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrocholoride
EP4186890A1 (en) Preparation of n-benzyl-2-(5-bromo-pyridin-2-yl)-acetamide for the synthesis of tirbanibulin
CN106478484A (en) A kind of method preparing Almogran key intermediate
CN106008323A (en) Preparation method of pimavanserin hemitartrate crystal form C
EP3178815B1 (en) Method for producing optically active 2-methylpiperazine
CN114507174A (en) Synthesis method of amisulpride impurity H
CN103209965A (en) Method for producing pyrazolinone salt
CN117756820A (en) Preparation method of levamisole hydrochloride

Legal Events

Date Code Title Description
FGI Letters patent sealed or granted (innovation patent)